Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Elderly, Children, Adult |
State: | Powder |
Purity: | >99% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product Name: Meglumine; n-methyl-d-glucamine
CAS: 6284-40-8
MF:C7H17NO5
MW:195.21
EINECS:228-506-9
MDL No.:MFCD00004707
Melting point:129-131.5 °C (lit.)
alpha -16.5 º (c=10, H2O, on dry sub)
Boiling point:331.88°C (rough estimate)
Density 1.2669 (rough estimate)
refractive index -16.5 ° (C=2, H2O)
RTECS LZ4295770
storage temp. 2-8°C
solubility H2O: 0.1 g/mL, clear, colorless
pkapKa 9.39(H2O,t =30.0,I=0.05N2)(Approximate)
form Crystalline Powder
color White to almost white
Purity: 99%
Package: 25kg/drum
Spec.:
Items | Specifications | Results |
Appearance | A white to almost white, crystalline powder | Conforms |
Solubility | Freely soluble in water and in methanol, paractically insoluble in acetone | Conforms |
Identification 1 | Infrared absorption: 197 M U Itraviolet absorption: 197U |
Conforms |
Identification 2 | Water: free soluble Ethanol(96%): free soluble Ethyl acetate: Practically insoluble |
Conforms |
Appearance of solution | Clear and not more intensely coloured than reference solution Y7 | Conforms |
Melting point | 137~140ºC | 137.5~139ºC |
PH | 5% (W/V) water solution; 7.0~9.0 | 7.82 |
Related substances | 2-chloropyridine-3 carboxylic acid≤ 0.2% 2-methyl-e-(trifluoromethyl) aniline≤ 0.2% Ethyl 2- chloropyridine-3-carboxylate ≤0.2% Ethyl 2-[[2-methyl-3-(trifuoromethyl)phenyl] amino] pyridine-3-carboxylate ≤0.2% |
Undetected Undetected Undetected Undetected |
Impurities |
|
Conforms Conforms Conforms |
Specific optical rotation | -9.0°~12.0° | -9.65° |
Solvent residue | Acetonitrile: ≤0.041% Methanol: ≤0.3% Ethanol: ≤0.5% Isopropanol: ≤0.5% Ethyl acetate: ≤0.5% |
0.03% Conforms Conforms Conforms Conforms |
Bacterial endotoxins | ≤4.54 EU/mg | 0.64 EU/mg |
Loss on drying | ≤0.5% | 0.25% |
Sulphated ash | ≤0.1% | 0.02% |
Residue on ignition | ≤0.2% | 0.075% |
Clarity & color of solution | Clear, less color than reference solution Y6, b.p(Vet) | Conforms |
Clarification | 1.2g funixin meglumine/8.8g water | Transparent |
Assay | 99~101% | 99.67% |
Explanation | Micronisarion 200+/-20um | |
Conclusion: comply with USP / EP |
Our Product list:
Abaloparatide | octenidine dihydrochloride | ABT-263 |
Abemaciclib | O-Desmethylgefitinib | ABT-737 |
Abiraterone | Osimertinib Mesylate | AZD0328 |
acalabrutinib | Pacritinib | AZD1236 |
ALTIRATINIB | Pazopanib HCL | AZD-1480 |
amfonelic acid | Peficitinib | AZD1656 |
Anlotinib | Pegdinetanib | AZD1775 |
Asciminib | ponatinib | AZD1981 |
Atipamezole HCl | Pyrotinib | AZD2014 |
Atuveciclib | R788(FOSTAMATINIB DISODIUM) | AZD4017 |
AV-951 | Radotinib | AZD4573 |
Avapritinib | ramelteon | AZD5069 |
Axitinib | Refametinib | AZD5153 |
Bafetinib | Ribociclib | AZD5213 |
bendamustine hydrochloride | Riviciclib hydrochloride | AZD5904 |
Binimetinib | ruxolitinib | AZD7325 |
Bosutinib | Saracatinib | AZD9150 |
brigatinib | Savolitinib | Batimastat |
Cabozantinib | Semaxanib | BMS202 |
Cabozantinib Maleate | Simotinib HCl | BMS-214662 |
Capmatinib | Solcitinib | Carfilzomib |
Cediranib | Sonolisib | CEP-40783 |
Cerdulatinib | Sulfatinib | CO-1686 |
Chiauranib | sunitinib | darolutamide |
Cinchocaine HCL | Sunitinib Maleate | EDO-S101 |
Cipatinib | Teniposide | emodepside |
Cobimetinib | Toceranib | EPZ-6438 |
Dacomitinib | Tofacitinib citrate | IPI-145 |
dasatinib | trametinib | LDE225 HCL |
Decernotinib | Vandetanib | MK2206 |
Donafenib | Volitinib | OSI-027 |
dovitinib | Voruciclib hydrochloride | OTSSP167 |
E7449 | WORTMANNIN | PD 98059 |
Entospletinib | Zibotentan(ZD4054) | PF-04691502 |
Erdafitinib | zuclopenthixol | PI-103 |
Erlotinib | larotrectinib | PLX3397 |
etoposide | Lerociclib dihydrochloride | PLX4720 |
Famitinib | Lesogaberan AZD3355 | PP-121 |
Filgotinib | levatinib | PQR309/Bimiralisib |
Firocoxib | Lorlatinib | Sapanisertib |
Flumatinib | Maraviroc | selinexor |
Foretinib | Masitinib mesylate | S-Ruxolitinib |
Fostamatinib | Mocetinostat | TAE684 |
Fruquintinib | neratinib | Tafamidis |
Gefitinib | tenapanor | |
Gilteritinib | Verteporfin | |
Golvatinib | WYE-354 | |
Henatinib | WYE-687 | Atezolizumab |
Icotinib | 4-IPP | Avelumab |
imatinib | A-770041 | Durvalumab |
imatinib mesylate | MLN4924 | Pembrolizumab |
Lapatinib | OTX-015 | Pertuzumab |
lapatinib ditosylate | PLX3397 Pexidartinib | Ramucirumab |
Midostaurin | WAY-600 | |
nilotinib | WEHI-539 | |
Oclacitinib maleate | WYE-125132 |
Shipping Terms | ||
By Express | By Air | By Sea |
Suitable for under 50kg Fast:3-4 days High cost Door to door service Easy to pick up the goods |
Suitable for more than 50kg Fast:3-4 days High cost Airport to airport Professional broker needed |
Suitable for more than 500kg Slow:15-30 days Low cost Port to port Professional broker needed |
Suppliers with verified business licenses